PerkinElmer has launched ready-to-use adeno-associated virus vectors (AAV) detection kits to support researchers working on gene therapies for a variety of serious diseases. The validated and fully automatable assays are built on PerkinElmer’s AlphaLISA technology which requires no separation and are optimised, no-wash AAV detection assays. Read More
In the Summer 2022 issue of DDW, Jessica Woodgate and Molly Edwards from life sciences recruitment company SciPro shared with DDW their ambition to champion female leaders across drug discovery through the founding of the Women in Discovery round table. Since then, the women-only environment has flourished but in the… Read More
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry news. Gene therapies have made the headlines over the last week, with treatments… Read More
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Gene therapies have made the headlines over the last week, with treatments… Read More
This is the latest episode of the free narrated DDW podcast, “Complex problems require complex solutions”. It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “How quantum computing can benefit drug discovery” and “Sitting down with Dr Michael… Read More
This is the latest episode of the free DDW podcast, “Complex problems require complex solutions”. It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “How quantum computing can benefit drug discovery” and “Sitting down with Dr Michael Hayden from… Read More
One critical bottleneck in Cell and Gene Therapy (CGT) manufacturing is the production of high-quality plasmid DNA (pDNA), a vital building block for mRNA-based vaccines, viral vector-based cell or gene therapies that require pDNA as a starting material. Building a robust supply of GMP-grade pDNA requires that quality be a… Read More
The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has launched a new Community of Experts (CoE) with the aim of harnessing real-world data (RWD) from social media. The organisation is calling on technology companies, data scientists and RWD experts to join… Read More
The National Institute for Health and Care Excellence (NICE) has published a positive recommendation for Takeda’s EXKIVITY (mobocertinib) for treating EGFR Exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapy within a Final Appraisal Document (FAD).1,2 In March 2022, Great Britain was the first… Read More
Listen to this article on the DDW Podcast: Jeff Willis, MD, PhD is a Senior Medical Director and retina specialist at Genentech. He talks to Lu Rahman about some of the company’s work developing medicine for eye disease and offers insight into the ophthalmology field today. Genentech is committed to advancing… Read More
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week started with World Diabetes Day on 14 November and… Read More
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week started with World Diabetes Day on 14 November and concluded… Read More
Robotics & Automation 2022 will take place from 30 November to 1 December 2022, at Festo, Esslingen, Stuttgard. The meeting is jointly organised by SLAS and ELRIG UK, and will focus on the application and interaction of robotics and automation in the traditional biological and chemical spaces, as well as… Read More
The annual Genesis conference will take place on 7 December 2022 in London, and 5,6 and 8 December online, bringing key opinion leaders, investors and innovators from across the life sciences sector under one roof to exchange insights, debate trends and generate deals. DDW’s Megan Thomas will be in attendance… Read More
Algorithmiq, a Helsinki-based quantum computing start-up, has entered into an engagement with IBM to progress in its exploration of quantum algorithms that attempt to solve complex issues in life sciences. Between IBM’s hardware, software and quantum applications expertise and Algorithmiq’s algorithm developers, the companies hope to explore… Read More
Recently, DDW reported on how over three million people have been invited to join Our Future Health. Andrew Roddam, CEO of Our Future Health, shares the impact research programmes such as this will have on drug discovery. Millions of people in the UK and around the world spend many years… Read More
